Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes
Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes
复制标题
DOI:
10.2337/diabetes.46.12.2115
复制
发表时间:
1997-12-01
期刊:
影响因子:
7.7
通讯作者:
Kishimoto, T
中科院分区:
文献类型:
--
作者:
Kurebayashi, S;Hirose, T;Kishimoto, T
Thiazolidinediones (TZDs) are known to have potent increases of insulin sensitivity, Because peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a receptor for TZDs, is mainly expressed in adipocytes, we tried to search the TZD-targeted genes in mouse 3T3-L1 adipocytes, By the mRNA differential display method, one band repressed by troglitazone was obtained, which corresponded to the partial sequences of the stearoyl-CoA desaturase 1 (SCD1) gene, Troglitazone dramatically decreased SCD1 mRNA levels in 3T3-L1 adipocytes in a dose-dependent manner. Pioglitazone also repressed the SCD1 mRNA expression, whereas WY-14,643 had no apparent effect. Both troglitazone and pioglitazone raised the composition (weight percentage) of myristic acid (C14:0), palmitic acid (C16:0), and stearic acid (C18:0), but lowered the composition of the Delta(9)-cis desaturated fatty acids such as myristoleic acid (C14:1, Delta(9)), palmitoleic acid (C16:1 Delta(9)), oleic acid (C14:1, Delta(9)), and linoleic acid (C18:2, Delta(9), (12)). These results indicate that TZDs repress SCD1 activity in 3T3-L1 adipocytes via downregulating SCD1 enzyme gene expression.